About

Biosolyx Co., Ltd. is a research-oriented company that creates value for our customers

History

2022
  • Awarded as a Daegu-Gyeongbuk High-Tech Venture Industry Awards Venture Company
  • MOU on the development of vaccines to prevent animal diseases signed
  • Joint research agreement for the development of pulmonary fibrosis treatment signed
  • Excellent technology evaluation company (TCB) T-3 Level Certification
  • KRW 300 million in seed investment attracted
2021
  • Production Technology Research Institute product certification
  • Gene delivery material patent registration
2020
  • Venture Business Certification
  • Selected as a TIPS project for start-up growth technology development project
  • Established affiliated research institute
2019
  • Biosolyx Co., Ltd. Establishment
  • Attracted KRW 150 million in seed investment